Vitamin D Supplementation and Clinical Improvement in COVID-19
NCT05126602 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2021-11-19
Summary
Background and objective Vitamin D is important as the interaction between vitamin D and its receptors at the immune cells stimulates innate and adaptive immunity. Deficiency in vitamin D is associated with increased susceptibility to infection and it is commonly found in Indonesia. Several studies indicate the potential of vitamin D supplementation against Coronavirus Disease 2019 (COVID-19), particularly in combating the proinflammatory situation as well as coagulopathy. This study aims to evaluate the supplementation of vitamin D in COVID 19 patients, particularly the changes in hematology parameters and other clinical parameters.
Method A double-blind randomized clinical trial is conducted among moderate COVID 19 patients. High-dose of vitamin D is given orally in the intervention group, compared with a low dose of vitamin D. Hematology parameters, D Dimer, conversion time on Polymerase Chain Reaction (PCR) test, and clinical symptoms are assessed
Hypothesis High Dose vitamin D shows a better hematology parameter, short PCR conversion time, and faster clinical recovery
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Vitamin D3 10000 IU
Tablet of 5000 IU of vitamin D3 given twice daily
- DIETARY_SUPPLEMENT
-
Vitamin D3 1000 IU
Tablet of 1000 IU of vitamin D3 given once daily
Sponsors & Collaborators
-
Bumi Herman
lead OTHER
Principal Investigators
-
Sisca Agustia, MD · Hasanuddin University
-
Amirah Faisal, MD · Hasanuddin University
-
Zahratul Fajri · Hasanuddin University
-
Nurpudji Taslim, Prof · Hasanuddin University
-
Suryani Armyn, Prof · Hasanuddin University
-
Haerani Rasyid, Prof · Hasanuddin University
-
Agussalim Bukhari, Prof · Hasanuddin University
-
Irawaty Djaharuddin, Prof · Hasanuddin University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-01
- Primary Completion
- 2021-09-30
- Completion
- 2021-11-01
Countries
- Indonesia
Study Locations
More Related Trials
-
Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico
NCT04793243 ·Status: COMPLETED ·Phase: NA
-
The Effect of Vitamin D Supplementation on COVID-19 Recovery
NCT04883203 ·Status: COMPLETED ·Phase: PHASE3
-
Cholecalciferol to Improve the Outcomes of COVID-19 Patients
NCT04411446 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness and Safety of Two Vitamin D3 Supplementation Regimens in Adults with Early-stage COVID-19
NCT06585995 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Supplementation in Patients With COVID-19
NCT04449718 ·Status: COMPLETED ·Phase: NA
-
Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients
NCT04386044 ·Status: COMPLETED
-
Severity of COVID-19 and Vitamin D Supplementation
NCT05166005 ·Status: UNKNOWN ·Phase: PHASE4
-
Can Vitamin D Reduce the Burden of COVID-19?
NCT07128069 ·Status: COMPLETED ·Phase: NA
-
Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
NCT04810949 ·Status: TERMINATED ·Phase: NA
-
Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection
NCT04636086 ·Status: COMPLETED ·Phase: PHASE4
-
Short Term, High Dose Vitamin D Supplementation for COVID-19
NCT04459247 ·Status: COMPLETED ·Phase: NA
-
Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin D3 Suppl
NCT06452082 ·Status: COMPLETED
-
COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation
NCT05037253 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers
NCT04535791 ·Status: COMPLETED ·Phase: PHASE3
-
Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19
NCT04868903 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection
NCT04519034 ·Status: COMPLETED
-
Effect of Vitamin D on Morbidity and Mortality of the COVID-19
NCT04552951 ·Status: UNKNOWN ·Phase: PHASE4
-
Vitamin D and COVID-19 Management
NCT04385940 ·Status: COMPLETED ·Phase: PHASE3
-
Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease
NCT04952857 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Vitamin D Supplementation on Glutathione Peroxidase (GPx) Activity, Interleukin-6 (IL-6) Levels and Clinical Outcomes in Post-COVID-19 Patients
NCT06419712 ·Status: COMPLETED ·Phase: NA
-
Vitamine D in Post-COVID Patients
NCT04969237 ·Status: COMPLETED
-
Oral 25-hydroxyvitamin D3 and COVID-19
NCT04386850 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study
NCT04525820 ·Status: COMPLETED ·Phase: NA
-
Impact of Vitamin D Supplementation on COVID-19 Vaccine Response and IgG Antibodies in Deficient Women.
NCT05447065 ·Status: COMPLETED ·Phase: NA
-
Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India
NCT04641195 ·Status: COMPLETED ·Phase: PHASE3